1. 1) Vanhoutte PM, Shimokawa H, Feletou M, Tang EH. Endothelial dysfunction and vascular disease—a 30th anniversary update. Acta Physiol., 219, 22–96 (2017).
2. 2) Rask-Madsen C, King GL. Kidney complications: factors that protect the diabetic vasculature. Nat. Med., 16, 40–41 (2010).
3. 3) McCarthy CG, Goulopoulou S, Wenceslau CF, Spitler K, Matsumoto T, Webb RC. Toll-like receptors and damage-associated molecular patterns: novel links between inflammation and hypertension. Am. J. Physiol. Heart Circ. Physiol., 306, H184–H196 (2014).
4. 4) Nunes KP, de Oliveira AA, Mowry FE, Biancardi VC. Targeting toll-like receptor 4 signalling pathways: can therapeutics pay the toll for hypertension? Br. J. Pharmacol., 176, 1864–1879 (2019).
5. 5) Pahwa R, Nallasamy P, Jialal I. Toll-like receptor 2 and 4 mediate hyperglycemia induced macrovascular aortic endothelial cell inflammation and perturbation of the endothelial glycocalyx. J. Diabetes Complications, 30, 563–572 (2016).